Aim Metabolic and bariatric surgery (MBS) is considered one of the most effective
interventions for weight loss and associated type-2 diabetes mellitus (T2DM) remission …

Purpose Bariatric surgery has proven to be the most efficient treatment for obesity and type 2
diabetes mellitus (T2DM). Despite detailed qualification, desirable outcome after an …

Abstract Background Roux-En-Y gastric bypass (RYGB) and Sleeve Gastrectomy (SG) have
shown to be two of the most effective interventions to enhance weight loss and associated …

Background Prediction of type 2 diabetes (T2DM) remission is an important part of risk-
benefit assessment before bariatric surgery. Study Design Advanced-DiaRem (Ad-DiaRem) …

OBJECTIVE Roux-en-Y gastric bypass (RYGB) induces type 2 diabetes remission (DR) in
60% of patients at 1 year, yet long-term relapse occurs in half of these patients. Scoring …

Objective Multiple scores validate long-term type-2 diabetes mellitus (T2DM) remission after
metabolic and bariatric surgery (MBS). However, studies comparing Roux-en-Y gastric …

Purpose The utility of available scoring systems for type 2 diabetes (T2D) remission
prediction after metabolic surgery has not been defined in a multi-ethnic Asian population …

Aim Bariatric metabolic surgery (BMS) is a proven treatment option for patients with both
obesity and type 2 diabetes mellitus (T2DM). However, there is a lack of comprehensive …

Background About 60% of patients with type 2 diabetes achieve remission after Roux-en-Y
gastric bypass (RYGB) surgery. No accurate method is available to preoperatively predict …

Aims The comparative efficacy of Roux‐en‐Y gastric bypass (RYGB) and sleeve
gastrectomy on Type 2 diabetes remission and the role of weight loss are unclear. The …